Preclinical study from NIH/Moderna: Correlates of SARS-CoV-2 immunity in non-human primates
Preclinical study from NIH/Moderna: Correlates of SARS-CoV-2 immunity in non-human primates Researchers in the United States have shown that the antibody response induced by the Moderna mRNA-1273 vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a correlate of immune protection against coronavirus disease 2019 (COVID-19) in non-human primates. “A critical issue for optimizing the use of COVID-19 vaccines is defining an immune correlate of protection,” says Robert Seder from the National Institutes of Health in Bethesda, Maryland, and colleagues. A defined cor...